Compare FMC Corp (FMC) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs Tilray Brands Inc — how do they compare? FMC Corp trades at $8.89 (market cap $1.39B), while Tilray Brands Inc trades at $3.61 (market cap $530.54M). The key difference: FMC Corp is far larger — about 2.6× Tilray Brands Inc's market cap, and FMC Corp pays a 3.59% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold FMC Corp for 68 Days and Tilray Brands Inc for 31 Days on average.
| FMC | TLRY | |
|---|---|---|
Market Cap | $1.39B | $530.54M |
Volume | 4,145,979 | 9,099,075 |
Sector | Basic Materials | Health |
52-Week High | $30.63 | $21.00 |
52-Week Low | $8.44 | $3.57 |
Typical Hold Time | 68 Days | 31 Days |
Enterprise Value | $5.19B | $684.46M |
Dividend Yield | 3.59% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC trades at $9.09, up 0.66% with bearish technical signals despite recent earnings beats. The agricultural sciences company faces severe profitability challenges with a -84.83% net margin and negative ROE, though valuation ratios appear attractive with P/S of 0.35 and P/B of 0.86. Recent developments include regulatory filings for new herbicides in Brazil and a minority equity investment from Tessenderlo Group.
While analyst consensus suggests moderate upside to the $14.60 price target, significant operational challenges and negative cash flow from operations in 2025 present substantial risks. The company's aggressive deleveraging efforts and new product pipeline offer potential catalysts, but investors face headwinds from cyclical industry pressures and persistent profitability issues.
TLRY trades at $3.715, down 1.72% on the day and near its 52-week low, reflecting persistent bearish technical momentum. The company reported revenue of $821.31M in 2025 but a substantial net loss of -$2.19B, with negative cash flow from operations. Recent quarters show consistent earnings misses versus expectations, though analyst consensus suggests a high price target of $65.01 amid mixed sentiment.
The outlook remains challenged by profitability issues and high debt, but potential catalysts include U.S. cannabis regulatory changes. Investment opportunities hinge on speculative regulatory shifts, while risks include ongoing losses, competitive pressures, and reliance on financing activities to sustain operations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
